Stock to buy: Anand Rathi assigns ‘Buy’ rating on Rossari Biotech shares, sees 26% upside
Anand Rathi has assigned a ‘Buy’ rating on Rossari Biotech shares with a target price of ₹950 apiece, implying an upside potential of nearly 26% from its Thursday’s closing price. The specialty chemicals manufacturer Rossari Biotech is embarking on substantial ₹180 crore capex to yield an asset turnover of 4-5x on optimal utilisation. Anand Rathi … Read more